Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127590601 | 12759060 | 1 | I | 0 | 20160915 | 20160915 | DIR | FDA-CTU | 55.00 | YR | F | N | 0.00000 | 20160830 | N | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127590601 | 12759060 | 1 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | 90MG Q12W SQ | 0 | 90 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127590601 | 12759060 | 1 | Psoriasis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127590601 | 12759060 | Abasia | |
127590601 | 12759060 | Blister | |
127590601 | 12759060 | Immune system disorder | |
127590601 | 12759060 | Impaired work ability | |
127590601 | 12759060 | Malaise | |
127590601 | 12759060 | Oropharyngeal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
127590601 | 12759060 | HP |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127590601 | 12759060 | 1 | 20150923 | 20160620 | 0 |